Flow cell for a flow cytometer system

Abstract
The flow cytometer system of the preferred embodiment includes a flow cell body that functions to contain, protect, and align the components of the flow cytometer system; a flow channel, coupled to the flow cell body, that functions to conduct and focus sample fluid through an interrogation zone; and a sample injection probe, removably coupled to the flow cell body, that functions to provide a uniform flow of sample fluid to the flow channel. The flow cytometer system is preferably designed for the flow cytometer field. The flow cytometer system, however, may be alternatively used in any suitable environment and for any suitable reason.
Description
TECHNICAL FIELD

This invention relates generally to the flow cytometer field, and more specifically to a flow cytometer system with a flow cell body, a flow channel, and a sample injection probe.


BACKGROUND

A typical flow cell for a flow cytometer system, which includes a flow channel, is composed of multiple pieces of fused silica that must be individually cast or cut and later assembled. The typical flow channel is susceptible to clogs and bubbles. A clog, which prevents flow of the sample fluid, may be caused by sample debris, conjugated or clustered cells, or other substances inserted into the flow path of the flow cytometer. Bubbles may interfere with the optical interrogation of the sample as it passes through the interrogation zone. Both clogs and bubbles within the flow channel can render experimental data useless, which in turn leads to repetitive experiments, increased costs, and lost time associated with the maintenance and operation of the flow cytometer.


Thus, there is a need for a flow cell that provides for improved construction and integration of its component parts, as well as a flow cytometer system that reduces the likelihood of clogs and bubbles in the flow channel. This invention provides such an improved and useful flow cytometer.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 is a cross section view of a first preferred embodiment of the invention.



FIGS. 2 and 3 are a side and perspective view, respectively, of a cross section of a variation of a first preferred embodiment of the invention.



FIGS. 4 and 5 are cross section views of a second preferred embodiment of the invention.



FIG. 6 is a perspective view of the flow cell body of a second preferred embodiment of the invention.



FIGS. 7 and 8 are a side and a cross section view, respectively, of the sample injection probe body of a second preferred embodiment of the invention.



FIG. 9 is a perspective view of a preferred embodiment of the assembly fixture.



FIG. 10 is an enlarged perspective view of the capillary receptacle and alignment element of the preferred embodiment.



FIG. 11 is a cross sectional view of the assembly fixture coupled to the flow cell body.





DESCRIPTION OF THE PREFERRED EMBODIMENTS

The following description of the preferred embodiments of the invention is not intended to limit the invention to these preferred embodiments, but rather to enable any person skilled in the art of flow cytometry to make and use this invention.


As shown in FIG. 1, the flow cytometer system of the preferred embodiment includes a flow cell body 110 that functions to contain, protect, and align the components of the flow cytometer system; a flow channel 112, coupled to the flow cell body 110, that functions to conduct and focus sample fluid through an interrogation zone; and a sample injection probe 114, removably coupled to the flow cell body 110, that functions to provide a uniform flow of sample fluid to the flow channel 112. The flow cytometer system is preferably designed for the flow cytometer field. The flow cytometer system, however, may be alternatively used in any suitable environment and for any suitable reason.


1. Flow Cell Body, Flow Channel, and Sample Injection Probe


The flow cell body 110 of the preferred embodiment functions to contain, protect, and align the components of the flow cytometer system. As shown in FIGS. 1-6, the flow cell body 112 is a unitary construction, which preferably includes a single piece of machined material that contains, protects, and aligns the remaining components of the flow cytometer system, including the flow channel 112. A suitable material for the unitary construction of the flow cell body 110 is polycarbonate, although any suitable metal, plastic, alloy, or composite material can be readily substituted for the unitary construction material.


The flow cell body 110 is preferably manufactured according to methods known in the art of manufacture, including for example CNC machining and injection molding or any combination thereof. The method of manufacture of the flow cell body 110 of the preferred invention includes the steps of providing a material, and disposing a receiving channel 116 in the material such that the receiving channel 116 is appropriately sized for receiving and holding the flow channel 112. Suitable materials include polycarbonate, although any suitable metal, plastic, alloy, or composite material can be readily substituted for material. The receiving channel 116 is preferably manufactured such that it provides an opening through which the flow channel 112 is radially exposed for the interrogation of the samples within the flow channel 112.


The flow channel 112 of the preferred embodiment is coupled to the flow cell body 110 and functions to conduct and focus sample fluid through an interrogation zone, where the sample material is analyzed. As shown in FIGS. 1 and 4, the flow channel 112 is preferably mounted within the flow cell body 110 and is typically a small passageway, typically less than 0.3 mm in diameter. The flow channel 112 is preferably made from an optical grade fused silica, but may alternatively be made from any suitable material such as suitable optically clear capillary materials. The flow channel preferably has a circular cross section, but may alternatively have any suitable cross section geometry. The sample fluid or sample material may be anything capable of being inserted into the flow path. Sample material may include cells, biological materials, or other particles to be assayed, measured, or counted.


The sample injection probe (SIP) 114 of the preferred embodiment is removably coupled to the flow cell body 110 and functions to provide a uniform flow of sample fluid to the flow channel 112. As shown in FIGS. 1 and 4, the SIP 114 of the preferred embodiment is preferably selectively removable from the flow cell body 110 and includes a small diameter capillary that functions to retrieve the sample fluid from a sample fluid reservoir or sample vial 144 and to pass the sample fluid upstream towards the flow channel 112. The small diameter of the SIP 114 functions to provide a uniform flow of sample fluid to the flow channel 112 and to minimize the injection of gases that may contribute to the formation of bubbles. The SIP 114 preferably has a cross section geometry that is substantially circular, however the cross section geometry may alternatively be any other suitable cross section geometry. The cross section geometry may change geometry or dimension along the length of the SIP 114. As shown in FIG. 4, the portion of the SIP 114 that extends into the sample vial 114 may have a larger diameter than the portion of the SIP 114 that extends towards the flow channel 112. The transition between the various diameters of the SIP 114 may have a shoulder with a small corner radius, as shown in FIG. 4, or may alternatively have any suitable corner radius or the transition may be tapered. The SIP 114 may be constructed of any suitable material, including for example non-corrosive rigid materials such as stainless steel, plastic or composite. The SIP 114 of the variation of the preferred embodiment is constructed of a single unitary piece, which may be fabricated through any known methods such as CNC machining, injection molding, and the like.


In a variation of the preferred embodiment, the flow cytometer system includes a SIP body 118, as shown in FIGS. 1-5. The SIP body 118 is removably coupled to the flow cell body 110 and functions to contain the SIP 114 and align the SIP 114 with the flow channel 112. The SIP body 118 includes a receiving channel 116′ preferably for receiving the SIP 114. The receiving channel 116′ is preferably appropriately sized for receiving and holding the SIP 114. The receiving channel 116′ preferably has a cross section geometry (that may change geometry or dimension along the length of the receiving channel 116′) appropriately sized for receiving and holding the SIP 114 and for aligning the SIP 114 with the flow channel 112. The receiving channel 116′ may be dimensioned such that the SIP 114 extends into the flow cell body 110, as shown in FIG. 1, or the receiving channel 116′ may be dimensioned such that the SIP 114 remains in the SIP body 118, as shown in FIG. 4. The receiving channel 116′ may removably and selectively receiving the SIP 114. Alternatively, the SIP 114 may be coupled to the SIP body 118, and the SIP body 118 is then removably and selectively coupled to the flow cell body 110. The SIP body 118 further includes a mating interface 120 for mating to the flow cell body 110. The mating interface 120 can include a tapered or conical geometry that is configured for precision alignment with the flow cell body 110 thus ensuring proper alignment of the SIP 114 and the flow channel 112. The mating interface can also include a threaded face 122 that complements a threaded receiver 124 on the flow cell body 110, thus providing for regular and precise mating of the SIP body 118 and the flow cell body 110 without the use of specialized tools.


The SIP body 118 may further define a circumferential groove 150 that functions to hold a back-up o-ring 158, or any other suitable element that will increase friction between the SIP body 118 and the flow cell body 110 at a point, that functions to create a seal and/or to create a removable press fit connection between the flow cell body 110 and the SIP body 118. The flow cytometer system may further include a plurality of o-rings. As shown in FIG. 4, the connection between the SIP body 118 and the flow cell body 110 may utilize at least one of a top o-ring 152, a first o-ring 154, a second o-ring 156, and the back-up o-ring 158. The top o-ring 152 preferably functions to seal the top of the SIP body 118 to the flow cell body 110, the first o-ring 154 preferably functions to seal the connection between the input channels 146 of the flow cell body 110 and the SIP body 118, and the second o-ring 156 preferably functions to balance the forces created by the first o-ring.


2. Assembly of the Flow Cytometer System


To ensure accurate analysis of the sample material, the flow channel 112 is preferably correctly aligned with the flow cell body 110. Due to the small size of the flow channel 112 (it is typically a capillary tube less than 0.3 mm in diameter), it is difficult to accurately radially align the capillary tube with the flow cell body 110 during assembly of the flow cell for a flow cytometer system. The flow cytometer is preferably assembled by a method with a device that facilitates the radial alignment of a capillary tube in a flow cell. The device is preferably the assembly fixture 10 of the preferred embodiments, but may alternatively be any suitable device used in any suitable method.


As shown in FIG. 9, the assembly fixture 10 of the preferred embodiments defines a capillary receptacle 12 adapted to receive a capillary tube for assembly, defines an alignment element 14 adapted to align the assembly fixture 10 with the flow cell body 110, and includes a coupling element 16 adapted to removably couple the assembly fixture 10 with a flow cell body 110. The assembly fixture 10 is, in some respects, a “golden tool” that facilitates a relaxed tolerance for the original bore for the capillary tube and facilitates accurate alignment in a faster, cheaper, reproducible manner. The assembly fixture 10 is preferably designed to facilitate the assembly of a flow cell and, more specifically, to properly radially align a capillary tube within a flow cell of a flow cytometer. The assembly fixture 10, however, may be alternatively used in any suitable environment and for any suitable reason.


The assembly fixture 10 of the preferred embodiments is an article of manufacture, preferably made out of a metal such as brass. The assembly fixture 10 may alternatively be made out of any suitable rigid material such as stainless steel, plastic or composite. The assembly fixture is preferably constructed of a single unitary piece, which may be fabricated through any known methods such as CNC machining, injection molding, and the like.


The capillary receptacle 12 of the preferred embodiments functions to receive a capillary tube for assembly. As shown in FIG. 10, the capillary receptacle 12 is preferably located at the top portion of the assembly fixture 10. The capillary receptacle 12 is preferably precision machined and or ground, but may alternatively be made in any suitable method to ensure accurate dimensions for the proper radial alignment of the capillary tube. The capillary receptacle 12 preferably has a cross section geometry and a depth. The cross section geometry is preferably substantially circular, such that the capillary tube fits into the receptacle and is radially aligned by the walls of the receptacle. The cross section geometry may alternatively be any suitable cross section geometry such that the capillary receptacle 12 receives and radially aligns a capillary tube. Additionally, the cross section geometry may change geometry or dimension along the length of the receptacle. Preferably, the cross section geometry is dimensioned such that the capillary tube will be radially aligned and therefore properly positioned with the flow cell body 110 upon assembly. The capillary receptacle 12 preferably has a depth such that a portion of the capillary tube remains exposed beyond the assembly fixture 10. The exposed portion of the capillary tube is preferably the portion of the capillary tube that couples to the flow cell body 110. Preferably, the depth is dimensioned such that the capillary tube will be axially aligned and therefore properly positioned with the flow cell body 110. The capillary tube is preferably coupled to the flow cell body 110 with adhesive, but may alternatively be connected by any other suitable material or suitable methods.


As shown in FIGS. 9, 10, and 11, the alignment element 14 of the preferred embodiments functions to align the assembly fixture 10 with the flow cell body 110. The alignment element 14 includes a mating interface that functions to mate the assembly fixture 10 and the flow cell body 110. The mating interface includes a geometry and dimensions that are configured for precision alignment with the flow cell body 110 thus ensuring proper radial and axial alignment of the assembly fixture 10 and the capillary tube. The mating interface is preferably precision machined and or ground, but may alternatively be made in any suitable method to ensure proper alignment geometry and dimensions.


The alignment element 14 preferably includes at least one of a nozzle region mating interface 20 and SIP body mating interface 22. The nozzle region mating interface 20 is preferably located at the top portion of the assembly fixture 10 and is substantially cylindrically shaped. The nozzle region mating interface 20 is preferably dimensioned such that it fits tightly with the flow cell nozzle region of the flow body. The SIP body mating interface 22 is preferably a tapered or conical geometry that is configured for precision alignment with the portion of the flow cell body 110 with which the SIP body mating interface 120 aligns. The dimensions of the SIP body mating interface 22 are preferably the same or similar to the mating interface 120 of the SIP body 118. The use of a tapered or conical geometry assures both a particular radial and axial mating between the flow cell and the assembly fixture. Other suitable dimensions may, however, be used.


The coupling element 16, as shown in FIG. 9, of the preferred embodiments functions to removably mount the assembly fixture 10 with a flow cell body 110. Additionally, the coupling element 16, with the alignment element 14, functions to radially and axially align the assembly fixture 10 with the flow cell body 110. Preferably, the coupling element 16 is one of several variations. In a first variation, as shown in FIG. 9, the coupling element 16 is a threaded face (exterior threads) that complements a threaded receiver (interior threads) on the flow cell body 110, thus providing for regular and precise mating of the assembly fixture 10 and the flow cell body 110 without the use of specialized tools. In a second variation, the coupling element is a friction coupling element, preferably an o-ring. In this variation, the assembly fixture 10 preferably defines a circumferential groove that functions to hold an o-ring or any other suitable element that will increase friction between the assembly fixture 10 and the flow cell body 110 at a point to create a removable press fit connection and/or to create a seal. The coupling element 16 may, however, utilize any other suitable means for removably coupling the assembly fixture 10 with the flow cell body 110.


The assemble fixture 10 of the preferred embodiment may further include a handle 18, as shown in FIGS. 9 and 11. The handle 18 of the preferred embodiments functions to provide a gripping surface used to couple and uncouple the assembly fixture 10 from the flow cell body 110. The handle 18 is preferably located at the bottom portion of the assembly fixture 10 and preferably at least a portion of the handle 18 remains exposed beyond the flow cell body 110 when the assembly fixture 10 is coupled to the flow cell body 110. The handle 18 is preferably cylindrically shaped and dimensioned such that the outer diameter of the handle is at least the size of the flow cell body 110. The handle 18 may alternatively be any other suitable shape or size to provide an accessible gripping surface. Additionally, the handle 18 may be knurled or include a grip material such as rubber, such that the handle is easily grasped and manipulated.


The assembly fixture 10 of the preferred embodiments is preferably used to assemble a flow cell. The method of assembling the flow cytometer system of the preferred embodiments includes providing a flow cell body 110, a capillary tube (flow channel 112), and an assembly fixture 10; coupling the capillary tube to the assembly fixture 10 in the capillary receptacle 12 of the assembly fixture 10; coupling the assembly fixture 10 to the flow cell body 110 and attaching the capillary tube to the flow cell body 110; and removing the assembly fixture 10 from the flow cell body 110. The method is preferably designed for the assembly of the flow channel 112 and the flow cell body 110 of the preferred embodiments. The method, however, may be alternatively used in any suitable environment and for any suitable reason.


The step that recites providing a flow cell body 110, a capillary tube (flow channel 112), and an assembly fixture 10, functions to provide the elements of the flow cytometer system that will be coupled together. The step that recites coupling the capillary tube to the assembly fixture 10 in the capillary receptacle 12 of the assembly fixture 10, functions to place the capillary tube in the capillary receptacle such that the capillary tube is radially aligned by the walls of the receptacle and a portion of the capillary tube remains exposed beyond the assembly fixture 10 and is axially aligned.


The step that recites coupling the assembly fixture 10 to the flow cell body 110 and attaching the capillary tube to the flow cell body 110, functions to couple the assembly fixture 10 with the correctly aligned capillary tube into the flow cell body 110, as shown in FIG. 11. The alignment element 14 of the assembly fixture 10 will properly align the assembly fixture 10 with the flow cell body 110 and therefore, the radially and axially aligned capillary tube will be guided into the correct portion of the flow cell body 110. The coupling element 16 of the assembly fixture 10 may be coupled with the flow cell body 110 ensuring proper position and alignment of the capillary tube within the flow cell body 110. Once the assembly fixture 10 is coupled to the flow cell body 110, the capillary tube is preferably attached to the flow cell body 110 with an adhesive or any other suitable device or method.


The step that recites removing the assembly fixture 10 from the flow cell body 110, functions to uncouple the coupling element 16 and remove the assembly fixture 10, leaving a properly assembled capillary tube in place within the flow cell body 110.


Although omitted for conciseness, the preferred embodiments include every combination and permutation of the assembly fixture 10, the capillary receptacle 12, the alignment element 14, the coupling element 16, the handle 18, and any method of assembling the capillary tube within a flow cell body 110 using the assembly fixture 10.


3. Other Aspects of the Invention


In a variation of the preferred embodiment, the flow cytometer system includes a bubble purge port 126, as shown in FIGS. 1-5. The bubble purge port 126 is connected to the flow cell body 110 upstream from (before) the interrogation zone and is fluidically coupled to the sample fluid flowing through the flow cell body 110. The bubble purge port 126 functions to selectively purge bubbles prior to their entry into the flow channel 112, thus preventing substantially all bubbles from interfering with the data collection in the interrogation zone. The bubble purge port 126 also functions to selectively clear sample debris, conjugated or clustered cells, or other substances from the nozzle region or hydrodynamic focusing region 128. The bubble purge port 126 may be located upstream or downstream from the hydrodynamic focusing region 128, as shown in FIGS. 1 and 4 respectively. The bubble purge port 126 can be operated manually by a user during operation of the flow cytometer. Alternatively, the bubble purge port 126 can be automated and adapted to respond to signals from a bubble detector adapted to detect the presence of bubbles approaching the flow channel 112.


In another variation of the preferred embodiment, the flow cytometer system includes a hydrodynamic focusing region 128, as shown in FIGS. 1-4. The hydrodynamic focusing region 128 is connected to the flow channel 112 and adapted to pass sample fluids into the flow channel 112 for interrogation. The hydrodynamic focusing region 128 preferably includes a nozzle having a substantially cylindrical body that is configured to receive a sample fluid and a sheath fluid, but may alternatively include any suitable device or method. The sheath fluid is pumped into the nozzle to focus the sample fluid into a core for passage through the flow channel 112. The sheath fluid is preferably pumped into the nozzle from an input channel 146, as shown in FIGS. 1-5. As the interaction between the sheath fluid and the sample fluid may cause bubbles, the nozzle is preferably disposed within the flow cytometer upstream of the bubble purge port 126 in thus permitting the purging of bubbles related to the focusing process.


In another variation of the preferred embodiment, the flow cytometer includes a SIP cleaning port 132, as shown in FIGS. 1-3. The SIP cleaning port is preferably connected to a portion the SIP body 118 and is preferably in fluidic communication with the SIP 114. The SIP cleaning port 132 functions to allow a user to relieve pressure from the SIP 114 and also to clean the SIP 114 by introducing sheath fluid therein. The SIP cleaning port 132 can also be connected within a portion of the flow cell body 110 such that the SIP cleaning port 132 is accessible through both the flow cell body 110 and the SIP body 118 thus allowing a user to use the SIP cleaning port 132 while the flow cytometer is fully assembled or in operation. As such, the SIP body 118 and the flow cell body 110 can be configured with passages through which the SIP cleaning port 132 can pass while remaining in fluidic communication with the SIP 114 and being accessible to the user.


In another variation of the preferred embodiment, the flow cytometer includes a pressure monitoring tube 134, as shown in FIG. 1. The pressure monitoring tube 134 is a sheath tube concentrically located about the SIP 114 in a substantially symmetrical manner. The pressure monitoring tube 134 functions to monitor the pressure within the SIP 114 to ensure that the influx of sample fluid is optimized for the introduction of the sheath fluid and the testing of the sample in the flow channel 112. The pressure monitoring tube 134 can be connected to the SIP cleaning port 132 thus permitting the substantially synchronized recognition of pressure in the SIP 114 and its release through the SIP cleaning port 132.


In another variation of the preferred embodiment, the flow cytometer includes a SIP filter 136, as shown in FIG. 1. The SIP filter 136 is connected at an upstream end of the SIP 114 substantially adjacent to the sample reservoir or sample vial 144. The SIP filter 136 functions to substantially remove any large or obtrusive particles prior to entry into the SIP 114 and the flow channel 112, thus reducing the probability of any clogs during operation of the flow cytometer. The SIP filter 136 can include a porous medium such as a synthetic fabric, polymer or composite weave, or metallic mesh having a predetermined pore size for filtering out particles having a selected diameter. In other embodiments, the flow cytometer can include more than one SIP filter 136, each of which can have substantially identical or substantially different pore sizes for providing redundancy in the filtering process.


In another variation of the preferred embodiment, the flow cytometer includes a sample vial mechanism 138, as shown in FIG. 1. The sample vial mechanism 138 functions to selectively hold and accurately align a sample vial 144 with the SIP 114. The sample vial mechanism 138 can be integrated into the SIP body 118, thus rendering it selectively connectable to the flow cell body 110. Alternatively, the sample vial mechanism 138 can be selectively connected to the SIP body 118. The sample vial mechanism 138 functions to properly align the sample vial 144 (which may be sealed and pressurized) with the SIP 114 for removal to the flow channel 112. The sample vial mechanism 138 includes a substantially cylindrical body portion that receives a substantially cylindrical sample vial 144. The sample vial mechanism 138 also includes a release mechanism 140 that allows a user to secure the sample vial 144 within the body portion and in communication with the SIP 114. The release mechanism 140 is configured such that the sample vial 144, when inserted or removed from the body portion, is limited in its movement to a single degree of freedom that is substantially parallel to the SIP 114, thus preventing any shearing, torquing or other damaging forces on the SIP 114 itself.


In another variation of the preferred embodiment, as shown in FIGS. 2, 3 and 5, the flow cytometer also includes a base plate 142. In this variation, the flow cell body 110 is preferably mounted to the base plate 142 with screws or other suitable fasteners, while the SIP body 118 is preferably mounted to the base plate 142 through a threaded interface or other suitable method or device. As shown in FIGS. 5, 7, and 8, the SIP body includes a threaded face 148 that complements a threaded receiver on the base plate. The use of the base plate 142 may reduce stress on the flow cell while still using a cone-in-cone fit to align the SIP 114 to the flow cell capillary.


In another variation of the preferred embodiment, as shown in FIG. 6, the flow cytometer also includes a retaining ring 160. The retaining ring 160, coupled to the flow cell body 110, that functions to apply an evenly distributed pressure around the diameter of the flow cell body 110 during assembly and use. The retaining ring 160 further functions as an alignment aid, providing a guide to precisely rotate the flow cell body. The retaining ring is preferably made from any suitable metal, plastic, rubber, alloy, or composite material.


In another variation of the preferred embodiment, as shown in FIG. 4, the flow cytometer also includes a lens 162. The lens 162 is preferably coupled to the flow cell body 110 adjacent to the interrogation zone and functions to focus an illumination source that impinges the interrogation zone. The illumination source is preferably a laser, but may alternatively be any suitable illumination source.


As a person skilled in the art of flow cytometry will recognize from the previous detailed description and from the figures and claim, modifications and changes can be made to the preferred embodiments of the invention without departing from the scope of this invention defined in the following claim.

Claims
  • 1. A flow cytometer system having an interrogation zone, the flow cytometer system comprising: a flow cell body that is a unitary construction and that contains and aligns components of the flow cytometer system;a focusing lens, coupled to and located within the flow cell body adjacent to the interrogation zone, configured to focus light that impinges the interrogation zone;a flow channel, coupled to the flow cell body, that conducts and focuses sample fluid through the interrogation zone;a sample injection probe, removably coupled to the flow cell body, that provides a sample fluid to the flow channel;a sample injection probe body, removably coupled to the flow cell body, that contains the sample injection probe and aligns the sample injection probe with the flow channel;a sample injection probe cleaning port, at least partially defined within the sample injection probe body and fluidically coupled to the sample injection probe, that is configured to relieve pressure from the sample injection probe and configured to clean the sample injection probe by introducing sheath fluid therein; anda bubble purge port fluidically coupled to the flow cell body and defined in the flow cell body upstream from the interrogation zone for a flow direction from the sample injection probe to the interrogation zone, wherein the bubble purge port is configured to selectively purge bubbles prior to their entry into the flow channel.
  • 2. The flow cytometer system of claim 1 wherein the flow cell body includes a receiving channel that receives and holds the flow channel and provides an opening through which the flow channel is radially exposed for an interrogation of the sample fluid within the flow channel.
  • 3. The flow cytometer system of claim 1 wherein the flow channel is mounted within the flow cell body and is a small diameter capillary made from an optically clear material.
  • 4. The flow cytometer system of claim 1 wherein the sample injection probe is a small diameter capillary made from a unitary piece of non-corrosive rigid material.
  • 5. The flow cytometer system of claim 1 wherein the sample injection probe body includes a mating interface for mating to the flow cell body.
  • 6. The flow cytometer system of claim 5 wherein the mating interface includes a conical geometry that is configured for alignment of the sample injection probe body with the flow cell body.
  • 7. The flow cytometer system of claim 5 wherein the sample injection probe body defines a circumferential groove that holds an o-ring, wherein the o-ring creates a seal and removably couples the sample injection probe body with the flow cell body.
  • 8. The flow cytometer system of claim 1 wherein the bubble purge port selectively clears debris prior to entry into the flow channel for the flow direction from the sample injection probe to the interrogation zone.
  • 9. The flow cytometer system of claim 1 further comprising a hydrodynamic focusing region, connected to the flow channel, that passes sample fluids into the flow channel for interrogation, wherein the hydrodynamic focusing region includes a nozzle, having a substantially cylindrical body, that is adapted to receive a sample fluid and a sheath fluid.
  • 10. The flow cytometer system of claim 1 wherein the sample injection probe cleaning port is further connected to the flow cell body.
  • 11. The flow cytometer system of claim 1 further comprising a pressure monitoring tube, concentrically located about the sample injection probe in a substantially symmetrical manner, that monitors the pressure within the sample injection probe.
  • 12. The flow cytometer system of claim 11 wherein the pressure monitoring tube is connected to a sample injection probe cleaning port, such that the recognition of pressure in the sample injection probe and release of the pressure in the sample injection probe through the sample injection probe cleaning port is substantially synchronized.
  • 13. The flow cytometer system of claim 1 further comprising a sample vial and a sample vial mechanism, wherein the sample vial mechanism selectively holds and accurately aligns the sample vial with the sample injection probe.
  • 14. The flow cytometer system of claim 13 further comprising a sample injection probe filter, connected at an upstream end of the sample injection probe and substantially adjacent to the sample vial, that substantially removes debris prior to entry into the sample injection probe and the flow channel, wherein the sample injection probe filter includes a porous medium having a predetermined pore size for filtering out particles having a selected diameter.
  • 15. The flow cytometer system of claim 1 further comprising a base plate, wherein the flow cell body and the sample injection probe body are mounted to the base plate.
  • 16. The flow cytometer system of claim 15 wherein the sample injection probe body further includes a threaded face and the base plate further includes a complimentary threaded receiver, wherein the threaded face and the threaded receiver are configured for mating of the sample injection probe body and the base plate.
  • 17. The flow cytometer system of claim 1 further comprising a retaining ring, coupled to the flow cell body, that applies a substantially evenly distributed pressure around the diameter of the flow cell body.
  • 18. The flow cytometer system of claim 1 wherein the bubble purge port is approximately orthogonal to the longitudinal axis of the flow channel.
  • 19. A flow cytometer system having an interrogation zone, the flow cytometer system comprising: a flow cell body that is a unitary construction and that contains and aligns components of the flow cytometer system;a focusing lens, coupled to and located within the flow cell body adjacent to the interrogation zone, configured to focus light that impinges the interrogation zone;a flow channel, coupled to the flow cell body, that conducts and focuses sample fluid through the interrogation zone;a sample injection probe, removably coupled to the flow cell body, that provides a sample fluid to the flow channel;a sample injection probe body, removably coupled to the flow cell body, that aligns the sample injection probe with the flow channel; anda sample injection probe cleaning port, at least partially defined within the sample injection probe body and fluidically coupled to the sample injection probe, that is configured to relieve pressure from the sample injection probe and configured to clean the sample injection probe by introducing sheath fluid therein.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Application No. 60/864,646 filed 7 Nov. 2006 and entitled “FLOW CELL FOR A FLOW CYTOMETER SYSTEM”, which is incorporated in its entirety by this reference.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/US2007/083991 11/7/2007 WO 00 1/19/2010
Publishing Document Publishing Date Country Kind
WO2008/058217 5/15/2008 WO A
US Referenced Citations (221)
Number Name Date Kind
3347273 Russell Jul 1960 A
3061128 Hakim Dec 1968 A
3672402 Bloemer Jun 1972 A
3819272 Crozier et al. Jun 1974 A
4112735 McKnight Sep 1978 A
4138879 Liebermann Feb 1979 A
4371786 Kramer Feb 1983 A
4448538 Mantel May 1984 A
4559454 Kramer Dec 1985 A
4570639 Miodownik Feb 1986 A
4691829 Auer Sep 1987 A
4755021 Dyott Jul 1988 A
4790653 North, Jr. Dec 1988 A
4818103 Thomas et al. Apr 1989 A
4824641 Williams Apr 1989 A
4826660 Smith et al. May 1989 A
4844610 North, Jr. Jul 1989 A
4933813 Berger Jun 1990 A
5028127 Spitzberg Jul 1991 A
5040890 North, Jr. Aug 1991 A
5043706 Oliver Aug 1991 A
5083862 Rusnak Jan 1992 A
5138868 Long Aug 1992 A
5139609 Fields et al. Aug 1992 A
5150037 Kouzuki Sep 1992 A
5150313 Van den et al. Sep 1992 A
5155543 Hirako Oct 1992 A
5204884 Leary et al. Apr 1993 A
5224058 Mickaels et al. Jun 1993 A
5230026 Ohta et al. Jul 1993 A
5270548 Steinkamp Dec 1993 A
5301685 Guirguis Apr 1994 A
5308990 Takahashi et al. May 1994 A
5367474 Auer et al. Nov 1994 A
5374395 Robinson et al. Dec 1994 A
5395588 North, Jr. et al. Mar 1995 A
5403552 Pardikes Apr 1995 A
5466946 Kleinschmitt et al. Nov 1995 A
5469375 Kosaka Nov 1995 A
5539386 Elliott Jul 1996 A
5552885 Steen Sep 1996 A
5559339 Domanik et al. Sep 1996 A
5616124 Hague et al. Apr 1997 A
5684480 Jansson Nov 1997 A
5739902 Gjelsnes et al. Apr 1998 A
5797430 Becke et al. Aug 1998 A
5798222 Goix Aug 1998 A
5804507 Perlov et al. Sep 1998 A
5883378 Irish et al. Mar 1999 A
5920388 Sandberg et al. Jul 1999 A
5960129 Kleinschmitt Sep 1999 A
5981180 Chandler et al. Nov 1999 A
6016376 Ghaemi et al. Jan 2000 A
6039078 Tamari Mar 2000 A
6067157 Altendorf May 2000 A
6070477 Mark Jun 2000 A
6091502 Weigl et al. Jul 2000 A
6097485 Lievan Aug 2000 A
6108463 Herron et al. Aug 2000 A
6110427 Uffenheimer Aug 2000 A
6115065 Yadid-Pecht et al. Sep 2000 A
6139800 Chandler Oct 2000 A
6154276 Mariella, Jr. Nov 2000 A
6156208 Desjardins et al. Dec 2000 A
6181319 Fujita et al. Jan 2001 B1
6183697 Tanaka et al. Feb 2001 B1
6288783 Auad Sep 2001 B1
6377721 Walt et al. Apr 2002 B1
6382228 Cabuz et al. May 2002 B1
6403378 Phi-Wilson et al. Jun 2002 B1
6427521 Jakkula et al. Aug 2002 B2
6431950 Mayes Aug 2002 B1
6456769 Furusawa et al. Sep 2002 B1
6469787 Meyer et al. Oct 2002 B1
6473171 Buttry et al. Oct 2002 B1
6519355 Nelson Feb 2003 B2
6522775 Nelson Feb 2003 B2
6568271 Shah et al. May 2003 B2
6587203 Colon Jul 2003 B2
6602469 Maus et al. Aug 2003 B1
6636623 Nelson et al. Oct 2003 B2
6675835 Gerner et al. Jan 2004 B2
6694799 Small Feb 2004 B2
6700130 Fritz Mar 2004 B2
6710871 Goix Mar 2004 B1
6718415 Chu Apr 2004 B1
6778910 Vidal et al. Aug 2004 B1
6809804 Yount et al. Oct 2004 B1
6816257 Goix Nov 2004 B2
6825926 Turner et al. Nov 2004 B2
6852284 Holl et al. Feb 2005 B1
6859570 Walt et al. Feb 2005 B2
6869569 Kramer Mar 2005 B2
6872180 Reinhardt et al. Mar 2005 B2
6890487 Sklar et al. May 2005 B1
6897954 Bishop et al. May 2005 B2
6901964 Kippe et al. Jun 2005 B2
6908226 Siddiqui et al. Jun 2005 B2
6912904 Storm, Jr. et al. Jul 2005 B2
6936828 Saccomanno Aug 2005 B2
6941005 Lary et al. Sep 2005 B2
6944322 Johnson et al. Sep 2005 B2
7009189 Saccomanno Mar 2006 B2
7012689 Sharpe Mar 2006 B2
7019834 Sebok et al. Mar 2006 B2
7024316 Ellison et al. Apr 2006 B1
7061595 Cabuz et al. Jun 2006 B2
7075647 Christodoulou Jul 2006 B2
7105355 Kurabayashi et al. Sep 2006 B2
7106442 Silcott et al. Sep 2006 B2
7113266 Wells Sep 2006 B1
7130046 Fritz et al. Oct 2006 B2
7232687 Lary et al. Jun 2007 B2
7262838 Fritz Aug 2007 B2
7274316 Moore Sep 2007 B2
7328722 Rich Feb 2008 B2
7362432 Roth Apr 2008 B2
7403125 Rich Jul 2008 B2
7471393 Trainer Dec 2008 B2
7520300 Rich Apr 2009 B2
7628956 Jindo Dec 2009 B2
7738099 Morrell Jun 2010 B2
7739060 Goebel et al. Jun 2010 B2
7776268 Rich Aug 2010 B2
7780916 Bair et al. Aug 2010 B2
7843561 Rich Nov 2010 B2
7857005 Rich et al. Dec 2010 B2
7903706 O'Shaughnessy et al. Mar 2011 B2
7981661 Rich Jul 2011 B2
7996188 Olson et al. Aug 2011 B2
8017402 Rich Sep 2011 B2
8031340 Rich et al. Oct 2011 B2
20010014477 Pelc et al. Aug 2001 A1
20010039053 Liseo et al. Nov 2001 A1
20020028434 Goix et al. Mar 2002 A1
20020049782 Herzenberg et al. Apr 2002 A1
20020059959 Qatu et al. May 2002 A1
20020080341 Kosaka Jun 2002 A1
20020123154 Burshteyn et al. Sep 2002 A1
20020192113 Uffenheimer et al. Dec 2002 A1
20030035168 Qian et al. Feb 2003 A1
20030048539 Oostman, Jr. et al. Mar 2003 A1
20030054558 Kurabayashi et al. Mar 2003 A1
20030062314 Davidson et al. Apr 2003 A1
20030072549 Facer et al. Apr 2003 A1
20030078703 Potts et al. Apr 2003 A1
20030129090 Farrell Jul 2003 A1
20030134330 Ravkin et al. Jul 2003 A1
20030148379 Roitman et al. Aug 2003 A1
20030175157 Micklash, II et al. Sep 2003 A1
20030202175 van den Engh et al. Oct 2003 A1
20030211009 Buchanan Nov 2003 A1
20030223061 Sebok et al. Dec 2003 A1
20030235919 Chandler Dec 2003 A1
20040031521 Vrane et al. Feb 2004 A1
20040048362 Trulson et al. Mar 2004 A1
20040112808 Takagi et al. Jun 2004 A1
20040119974 Bishop et al. Jun 2004 A1
20040123645 Storm, Jr. et al. Jul 2004 A1
20040131322 Ye et al. Jul 2004 A1
20040143423 Parks et al. Jul 2004 A1
20040175837 Bonne et al. Sep 2004 A1
20040197768 Glencross Oct 2004 A1
20040201845 Quist et al. Oct 2004 A1
20040246476 Bevis et al. Dec 2004 A1
20050044110 Herzenberg et al. Feb 2005 A1
20050047292 Park et al. Mar 2005 A1
20050057749 Dietz et al. Mar 2005 A1
20050069454 Bell Mar 2005 A1
20050073686 Roth et al. Apr 2005 A1
20050078299 Fritz et al. Apr 2005 A1
20050105091 Lieberman et al. May 2005 A1
20050162648 Auer et al. Jul 2005 A1
20050163663 Martino et al. Jul 2005 A1
20050195605 Saccomanno et al. Sep 2005 A1
20050195684 Mayer Sep 2005 A1
20050252574 Khan et al. Nov 2005 A1
20060002634 Riley et al. Jan 2006 A1
20060015291 Parks et al. Jan 2006 A1
20060023219 Meyer et al. Feb 2006 A1
20060161057 Weber et al. Jul 2006 A1
20060177937 Kurabayashi et al. Aug 2006 A1
20060219873 Martin et al. Oct 2006 A1
20060280061 Koreeda et al. Dec 2006 A1
20060281143 Liu et al. Dec 2006 A1
20060286549 Sohn et al. Dec 2006 A1
20070003434 Padmanabhan et al. Jan 2007 A1
20070041013 Fritz et al. Feb 2007 A1
20070096039 Kapoor et al. May 2007 A1
20070124089 Jochum et al. May 2007 A1
20070127863 Bair et al. Jun 2007 A1
20070144277 Padmanabhan et al. Jun 2007 A1
20070212262 Rich Sep 2007 A1
20070224684 Olson et al. Sep 2007 A1
20070243106 Rich Oct 2007 A1
20080055595 Olson et al. Mar 2008 A1
20080064113 Goix et al. Mar 2008 A1
20080092961 Bair et al. Apr 2008 A1
20080152542 Ball et al. Jun 2008 A1
20080215297 Goebel et al. Sep 2008 A1
20080228444 Olson et al. Sep 2008 A1
20080246949 Harris et al. Oct 2008 A1
20090104075 Rich Apr 2009 A1
20090174881 Rich Jul 2009 A1
20090201501 Bair et al. Aug 2009 A1
20090202130 George et al. Aug 2009 A1
20090216478 Estevez-Labori Aug 2009 A1
20090257339 Katayama Oct 2009 A1
20090260701 Rich Oct 2009 A1
20090293910 Ball et al. Dec 2009 A1
20100008204 Bae et al. Jan 2010 A1
20100012853 Parks et al. Jan 2010 A1
20100032584 Dayong et al. Feb 2010 A1
20100119298 Huang May 2010 A1
20100302536 Ball et al. Dec 2010 A1
20100319469 Rich Dec 2010 A1
20100319786 Bair et al. Dec 2010 A1
20110008816 Ball et al. Jan 2011 A1
20110058163 Rich Mar 2011 A1
20110061471 Rich et al. Mar 2011 A1
20110306031 Rich Dec 2011 A1
Foreign Referenced Citations (33)
Number Date Country
466490 Jan 1992 EP
1391611 Feb 2004 EP
1396736 Mar 2004 EP
1521076 Sep 2004 EP
1521076 Apr 2005 EP
356169978 Dec 1981 JP
5913689 Mar 1984 JP
6353901 Apr 1988 JP
04-086546 Mar 1992 JP
6194299 Jul 1994 JP
06221988 Dec 1994 JP
7260084 Oct 1995 JP
08201267 Aug 1996 JP
09288053 Nov 1997 JP
10-227737 Aug 1998 JP
2001050887 Feb 2001 JP
2001170062 Jun 2001 JP
2003262201 Sep 2003 JP
200477484 Mar 2004 JP
9956052 Nov 1999 WO
0194914 Dec 2001 WO
2005017499 Aug 2004 WO
WO 2005017499 Feb 2005 WO
2005068971 Jul 2005 WO
2005073694 Aug 2005 WO
2005091893 Oct 2005 WO
2006055722 May 2006 WO
2007067577 Jun 2007 WO
2007100723 Sep 2007 WO
2007103969 Sep 2007 WO
2007136749 Nov 2007 WO
2008058217 May 2008 WO
2010101623 Sep 2010 WO
Related Publications (1)
Number Date Country
20100118298 A1 May 2010 US
Provisional Applications (1)
Number Date Country
60864646 Nov 2006 US